Loading...
XSTO
PAX
Market cap163mUSD
Jun 09, Last price  
82.60SEK
1D
-1.20%
1Q
32.80%
IPO
634.22%
Name

Paxman AB (publ)

Chart & Performance

D1W1MN
P/E
39.07
P/S
6.21
EPS
2.11
Div Yield, %
Shrs. gr., 5y
3.48%
Rev. gr., 5y
24.30%
Revenues
253m
+20.41%
31,332,00058,023,00085,279,00078,053,00096,202,000156,746,000210,117,000253,007,000
Net income
40m
+382.55%
-6,725,000-7,101,0002,756,000-19,186,000-12,776,000-10,324,0008,330,00040,196,000
CFO
39m
+150.15%
-7,133,000400,0003,305,000-8,484,000-4,143,0002,686,00015,632,00039,104,000

Profile

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment in Europe, the United States, Mexico, Japan, Oceania, rest of Asia, and South and Central America. It serves various cancer centers and hospitals. The comapny has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.
IPO date
Jun 12, 2017
Employees
82
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
253,007
20.41%
210,117
34.05%
156,746
62.93%
Cost of revenue
77,587
63,698
57,325
Unusual Expense (Income)
NOPBT
175,420
146,419
99,421
NOPBT Margin
69.33%
69.68%
63.43%
Operating Taxes
1,304
(361)
1,762
Tax Rate
0.74%
1.77%
NOPAT
174,116
146,780
97,659
Net income
40,196
382.55%
8,330
-180.69%
(10,324)
-19.19%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
13,485
11,038
12,728
Long-term debt
808
2,532
4,257
Deferred revenue
4,257
Other long-term liabilities
5,676
3,961
(4,257)
Net debt
(26,017)
(11,411)
(21,155)
Cash flow
Cash from operating activities
39,104
15,632
2,686
CAPEX
(16,188)
(11,724)
(35,692)
Cash from investing activities
(24,496)
(25,329)
(36,691)
Cash from financing activities
721
(3,414)
(169)
FCF
148,944
144,413
79,464
Balance
Cash
40,310
24,981
38,092
Long term investments
48
Excess cash
27,660
14,475
30,303
Stockholders' equity
27,342
8,688
Invested Capital
183,963
124,013
120,374
ROIC
113.07%
120.12%
75.99%
ROCE
94.61%
104.47%
76.18%
EV
Common stock shares outstanding
19,081
19,081
19,012
Price
65.60
78.26%
36.80
-14.62%
43.10
-33.69%
Market cap
1,251,712
78.26%
702,180
-14.31%
819,439
-27.84%
EV
1,225,695
690,769
808,608
EBITDA
191,638
165,029
116,839
EV/EBITDA
6.40
4.19
6.92
Interest
4,663
7,346
Interest/NOPBT
3.18%
7.39%